https://new.immunopaedia.com/wp-content/uploads/2025/03/Nafessa.jpeg
Naffesa Abdul Munim Al Sheikh wears multiple hats in the medical and scientific community – she is a medical lab scientist, a researcher, a histotechnologist, a lecturer, and proud to be an Immunopaedia ambassador. Nafessa is originally from Sudan, but now calls Oman home. Her scientific journey has been one of exploration and dedication to understanding the complexities of human health, particularly in the realm of immunology. Whether it is conducting research, teaching future scientists, or advocating for immunology education, Nafessa is passionate about making a difference in the world of healthcare.
We would love to hear more about your ongoing research. What projects are you working on and how do they impact the field?
My research focuses on systemic lupus erythematosus (SLE) with a focus on lupus nephritis, post-kala-azar dermal leishmaniasis (PKDL), and COVID-19. I’m also interested in studying regulatory T cells (Tregs) and their role in these diseases.
What specifically stood out about Immunopaedia that made you want to be an ambassador?
Several aspects of Immunopaedia stood out to me and fuelled my desire to become an ambassador. First, Immunopaedia’s commitment to advancing global immunology education through accessible, high-quality resources aligns perfectly with my passion for education and public outreach. The comprehensive content provided by Immunopaedia offers a wide audience—from students to seasoned professionals— immunology knowledge.
Additionally, Immunopaedia’s focus on fostering a global community of immunologists is particularly inspiring. I am deeply motivated by the opportunity to collaborate with and learn from colleagues worldwide, which not only broadens my perspectives but also enhances the collective knowledge and innovation within the field.
Immunopaedia published critical information during the COVID-19 pandemic which highlighted its impact and relevance in real-time public health crises. I found this inspiring as a researcher.
Being an Immunopaedia Ambassador allows me to contribute to a mission I am passionate about—promoting immunology education.
There are many areas of science and immunology is quite broad and complex. What inspired you to choose this branch of science over others?
I chose immunology as it intersects with multiple areas of biomedical science and immune responses are key to the development of many common diseases and malignancy treatments. I feel most scientists would be able to find an area of immunology that would suit their curiosity or interests.
Based on your own experience, what one piece of advice would you give someone who wants to study/research immunology?
Dive deep into the literature and stay curious. Immunology is a rapidly evolving field, so staying up-to-date and asking questions is the key to success.
If not immunology, then what? Which other field(s) would have benefited from your contribution and why?
Human rights! My background in immunology can contribute significantly to human rights work, especially in areas like health equity and access to healthcare. Understanding the intersection of health and human rights is crucial, and my expertise can provide valuable insights into developing policies and initiatives to improve healthcare access for marginalized communities.
What has been a moment of unexpected joy or surprise in your scientific career that has stayed with you?
Although my main major was in histopathology and cytology, I’ve found myself increasingly drawn to the interdisciplinary nature of immunology. Exploring immunology has opened new avenues and has allowed me to approach health and disease from a broader perspective. This shift has been both unexpected and rewarding, I now have new passions and opportunities for growth.
To have a better understanding of where your input lies in immunology, may we have your most recent publications?
Al. Kharusi, M.; Al Sheikh, N.; Alhajri, M.; Al. Mandhri, S.A.; Khafagy, E.-S.; Moglad, E.H.; Alotaibi, H.F.; Hegazy, W.A.H. A Prospective Cohort Study of COVID-19: Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death. Healthcare 2023, 11, 1025. https://doi.org/10.3390/healthcare11071025
